Estepan Ian Michael (CIK 0001836254)

Latest company ownership

Shares held
206,487
Last filed at
Sep 5, 2025
Confidence Score
27.3
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 16, 2025 Dec 18, 2025 Sarepta Therapeutics, Inc. COO Sell 20.0 -13,187 -6.39% ✗ $294.2K
Mar 7, 2025 Mar 11, 2025 Sarepta Therapeutics, Inc. CFO Sell 92.5 +4,335 7.44% ✗ $394.6K
Mar 6, 2025 Mar 10, 2025 Sarepta Therapeutics, Inc. CFO Sell 37.5 -9,679 -15.50% ✗ $1M
Mar 4, 2025 Mar 6, 2025 Sarepta Therapeutics, Inc. CFO Sell 42.5 -1,370 -2.96% ✗ $138.8K
Mar 3, 2025 Mar 4, 2025 Sarepta Therapeutics, Inc. CFO Sell 42.5 -557 -1.19% ✗ $57.8K
Jan 29, 2025 Jan 31, 2025 Sarepta Therapeutics, Inc. CFO Sell 20.0 -2,613 -5.28% ✗ $307.1K
Aug 30, 2024 Sep 3, 2024 Sarepta Therapeutics, Inc. CFO Sell 20.0 -5,985 -14.99% ✗ $822.1K
Jun 21, 2024 Jun 25, 2024 Sarepta Therapeutics, Inc. CFO Sell 40.0 -2,483 -5.85% ✗ $408.8K
Mar 7, 2024 Mar 11, 2024 Sarepta Therapeutics, Inc. CFO Sell 42.5 -1,561 -4.14% ✗ $190.8K
Mar 4, 2024 Mar 6, 2024 Sarepta Therapeutics, Inc. CFO Sell 42.5 -1,389 -3.55% ✗ $174.1K
Mar 1, 2024 Mar 5, 2024 Sarepta Therapeutics, Inc. CFO Sell 95.0 +4,435 12.79% ✗ $200K
Mar 8, 2023 Mar 10, 2023 Sarepta Therapeutics, Inc. CFO Sell 42.5 -744 -2.10% ✗ $114K
Mar 6, 2023 Mar 8, 2023 Sarepta Therapeutics, Inc. CFO Sell 90.0 +3,130 9.69% ✗ $215.4K
Mar 1, 2023 Mar 3, 2023 Sarepta Therapeutics, Inc. CFO Sell 42.5 -378 -1.16% ✗ $55.8K
Mar 4, 2022 Mar 8, 2022 Sarepta Therapeutics, Inc. CFO Sell 95.0 +6,294 23.86% ✗ $135.2K
Mar 1, 2022 Mar 1, 2022 Sarepta Therapeutics, Inc. CFO Sell 46.3 -376 -1.41% ✗ $28.2K
Sep 8, 2021 Sep 9, 2021 Sarepta Therapeutics, Inc. CFO Sell 42.5 -1,623 -5.72% ✗ $127.1K
Feb 28, 2021 Mar 10, 2021 Sarepta Therapeutics, Inc. CFO Sell 95.0 +14,334 102.08% ✗ $57.1K